Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (HaploHCT) Following Reduced Intensity Conditioning (RIC) for Selected High Risk Non-Malignant Diseases

This is a Phase II study for the use of T-cell replete reduced intensity conditioning (RIC) haploidentical donor allogeneic hematopoietic cell transplantation (HaploHCT) for individuals with high-risk non-malignant diseases who lack a suitable HLA-matched sibling donor.

NCT: NCT03367546

Locations: Masonic Caner Center at University of Minnesota, University of Minnesota Medical Center, Fairview

Link: https://clinicaltrials.gov/ct2/show/NCT03367546?recrs=ad&cond=Sickle+Cell+Anemia&locn=University+of+Minnesota&cntry=US&age=0&draw=2&rank=2